Genomic alterations associated with pseudoprogression and hyperprogressive disease during anti-PD1 treatment for advanced non-small-cell lung cancer

IntroductionThis study aimed to elucidate the relationship between dynamic genomic mutation alteration and pseudoprogression (PsPD)/hyperprogressive disease (HPD) in immunotherapy-treated advanced non-small-cell lung cancer (NSCLC), to provide clinical evidence for identifying and distinguishing bet...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Rui Zhou, Fan Tong, Yongchang Zhang, Ruigang Zhang, Yawen Bin, Sheng Zhang, Nong Yang, Xiaorong Dong
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Frontiers Media S.A. 2023-11-01
Rangatū:	Frontiers in Oncology
Ngā marau:	next-generation sequencing analysis pseudoprogression hyperprogressive disease anti-PD1 treatment non-small cell lung cancer
Urunga tuihono:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1231094/full
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!